A federal judge blocks Colorado's 70% price cap on Amgen's Enbrel, ruling the first-in-nation limit preempted by federal patent law.

A federal judge blocked a Colorado state panel from placing a cap on the price of Enbrel, a blockbuster drug sold by Amgen

A federal judge blocks Colorado's 70% price cap on Amgen's Enbrel, ruling the first-in-nation limit preempted by federal patent law.